Carisma Therapeutics to go public through merger with Boston-area biopharm firm

The company has also secured commitments from a syndicate of investors — which include Penn Medicine — for a $30 million financing.

Previous 2022 Best Places to Work: One Florida Bank offers its staff on-site dry cleaning and a car detailing service
Next Excela Health names new SVP, chief information officer

No Comment

Leave a reply

Your email address will not be published.